As part of its Morning Rounds series, a panel of specialists dives into the latest bladder cancer treatments, analyzing how recent clinical trial results are influencing their approach.
EP. 1: Case Study: Recognizing the Typical Signs of Bladder Cancer
Expert panelists unpack a patient's bladder cancer presentation, evaluating the presence of typical signs and symptoms that could lead to a diagnosis.
EP. 2: Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Experts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.
Tivozanib Combo Yields Similar PROs to Monotherapy in Advanced Clear Cell RCC
Dose Reductions Possible for Tivozanib With and Without Nivolumab for RCC
Nivolumab Combo for RCC Necessitates AE Monitoring, Awareness
Proactive Onco-Coaching Linked to Higher OS in mRCC